TIVO-1 Trial Results Data Approves Tivozanib in EU for RCC - 102191

Spotlight
Video

TIVO-1 Trial Results Data Approves Tivozanib in EU for RCC

Cancer-News has 56 videos Subscribe Here

Loading........
Description: Michael N. Needle, MD, and Chief Medical Officer of AVEO Oncology goes over the TIVO-1 Trial results first released in 2014. On August 28, 2017 it was announces that Tivozanib (FOTIVDA®) has been approved in the EU for RCC patients.
Shared By : Cancer-News
Posted on : 09/18/17
Added : 7 months ago
Category : Kidney Cancer

Tags: Tivozanib